Burkitt Lymphoma Survival Improves For Some Insciences Organisation The same regimen of intensive chemotherapy and the monoclonal antibody rituximab are recommended for most patients. “There was little available for Burkitt lymphoma in terms of prognostic factors, indicators, or scoring,” said Dr. Jorge Castillo ... |
